Serum Proteomic Signatures Predict Relapse in Rheumatoid Arthritis Patients Undergoing DMARD Withdrawal

O'Neil L, Spicer V, Hitchon CA, Rech J, Hueber A, Wilkins J, El-Gabalawy H, Schett G (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Arthritis and Rheumatology Wiley

Book Volume: 69

Authors with CRIS profile

Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Axel Hueber Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

University of Manitoba CA Canada (CA)

How to cite

APA:

O'Neil, L., Spicer, V., Hitchon, C.A., Rech, J., Hueber, A., Wilkins, J.,... Schett, G. (2017). Serum Proteomic Signatures Predict Relapse in Rheumatoid Arthritis Patients Undergoing DMARD Withdrawal.

MLA:

O'Neil, Liam, et al. "Serum Proteomic Signatures Predict Relapse in Rheumatoid Arthritis Patients Undergoing DMARD Withdrawal." 2017.

BibTeX: Download